Spotlight

A major goal of Dr Jean’s current antiviral research programs, presently funded by the Canadian Institutes of Health Research (CIHR), is to increase our understanding of human viral pathogenesis by identifying and studying the enzymes that control the viral and host-cell pathways essential for viral infection and disease progression and by developing protease inhibitors to interrupt these enzymatic pathways.